Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira‐Silva, Gwen Falony, Eugeni Belda, et al.
Nature (2020) Vol. 581, Iss. 7808, pp. 310-315
Open Access | Times Cited: 373

Showing 26-50 of 373 citing articles:

Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease
Nadja Paeslack, Maximilian Mimmler, Stefanie I. Becker, et al.
Amino Acids (2022) Vol. 54, Iss. 10, pp. 1339-1356
Open Access | Times Cited: 84
The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice
Yong Fan, René Klinkby Støving, Samar Berreira Ibraim, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 787-802
Open Access | Times Cited: 81
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 71
Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling
Jianlong Yan, Yanbin Pan, Wenming Shao, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 69
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 65
Understanding the molecular mechanisms of statin pleiotropic effects
Charles German, James K. Liao
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1529-1545
Open Access | Times Cited: 62
Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models
Rosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 3, pp. 399-408
Open Access | Times Cited: 61
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 53
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective
Mireia Vallès-Colomer, Cristina Menni, Sarah Berry, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 551-561
Closed Access | Times Cited: 51
Enterosignatures define common bacterial guilds in the human gut microbiome
Clémence Frioux, Rebecca Ansorge, Ezgi Özkurt, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 7, pp. 1111-1125.e6
Open Access | Times Cited: 50
Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease
Xin Zhou, Xiaotao Shen, Jethro S. Johnson, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 4, pp. 506-526.e9
Open Access | Times Cited: 47
Roles of the gut microbiome in weight management
Rachel N. Carmody, Jordan E. Bisanz
Nature Reviews Microbiology (2023) Vol. 21, Iss. 8, pp. 535-550
Closed Access | Times Cited: 42
Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development
Raúl Y. Tito, Sara Verbandt, Marta Aguirre Vázquez, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1339-1348
Open Access | Times Cited: 34
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Jianqing She, Gulinigaer Tuerhongjiang, Manyun Guo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 408-421.e5
Open Access | Times Cited: 21
Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA
Shengxi Jin, Peng Chen, Jing Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review
Hongcai Li, Jingjing Liang, Mengzhen Han, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk
Tiange Wang, Zhun Shi, Huahui Ren, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1722-1731
Closed Access | Times Cited: 16
Gut microbiota link dietary fiber intake and short-chain fatty acid metabolism with eating behavior
Evelyn Medawar, Sven‐Bastiaan Haange, Ulrike Rolle‐Kampczyk, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 92
Human and preclinical studies of the host–gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health
François Brial, Julien Chilloux, Trine Nielsen, et al.
Gut (2021) Vol. 70, Iss. 11, pp. 2105-2114
Open Access | Times Cited: 91
Towards a mechanistic understanding of reciprocal drug–microbiome interactions
Michael Zimmermann, Kiran Raosaheb Patil, Athanasios Typas, et al.
Molecular Systems Biology (2021) Vol. 17, Iss. 3
Open Access | Times Cited: 86
Successional Stages in Infant Gut Microbiota Maturation
Leen Beller, Ward Deboutte, Gwen Falony, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 86
The Gut Microbiome and Individual-Specific Responses to Diet
Avner Leshem, Eran Segal, Eran Elinav
mSystems (2020) Vol. 5, Iss. 5
Open Access | Times Cited: 78
The role of the gut microbiota in health and cardiovascular diseases
Lu Wang, Shiqi Wang, Qing Zhang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 67
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Rima Chakaroun, Lisa Olsson, Fredrik Bäckhed
Nature Reviews Cardiology (2022) Vol. 20, Iss. 4, pp. 217-235
Closed Access | Times Cited: 67
Metabolic control by the microbiome
Timothy Cox, Patrick Lundgren, Kirti Nath, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 63

Scroll to top